Načítá se...

Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers

Hsp90 is an ATP dependent molecular chaperone protein which integrates multiple oncogenic pathways. As such, Hsp90 inhibition is a promising anti-cancer strategy. Several inhibitors that act on Hsp90 by binding to its N-terminal ATP pocket have entered clinical evaluation. Robust pre-clinical data s...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Jhaveri, Komal, Taldone, Tony, Modi, Shanu, Chiosis, Gabriela
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3288123/
https://ncbi.nlm.nih.gov/pubmed/22062686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbamcr.2011.10.008
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!